ProCE Banner Activity

Simplifying to 2-Drug ART: Safety and Tolerability Considerations

Clinical Thought

Two-drug ART continues to be a nice simplification strategy for people with HIV. Read my commentary on recent data presented at the Fall 2022 Conferences highlighting safety and tolerability of 2-drug regimens.

Released: December 23, 2022

Expiration: December 22, 2023

Share

Faculty

Darcy Wooten

Darcy Wooten, MD, MS

Clinical Professor of Medicine
ID Fellowship Program Director
Division of Infectious Diseases and Global Public Health
University of California
San Diego, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Faculty Disclosure

Primary Author

Darcy Wooten, MD, MS

Clinical Professor of Medicine
ID Fellowship Program Director
Division of Infectious Diseases and Global Public Health
University of California
San Diego, California

Darcy Wooten, MD, has no relevant financial relationships to disclose.